Autori: Ricci M

Filtra

Data

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in na‹ve patients with spinal muscular atrophy and following switch from other therapies

Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?

A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?

Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey

Long term follow-up of scoliosis progression in type II SMA patients

Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Torna in alto